HighCape Capital Acquisition Corp.

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: HighCape Capital Acquisition
IPO Size: $100M
Underwriters: Cantor Fitzgerald
Focus: Life Sciences
SEC Filings: 1816431
Public Embarc Page: https://embarc.com/capital/spac/1816431/CAPA/highcape-capital-acquisition
IPO Ticker: CAPA

SPAC Leadership

Information on the SPAC leadership.

DirectorDavid Colpman
DirectorAntony Loebel, M.D.
DirectorRobert Taub
Chief Executive Officer and Chairman of the Board of DirectorsKevin Rakin(Partner High Cape Capital, Former CEO of BioHealing)
Chief Financial Officer, Chief Operating Officer and DirectorMatt Zuga

Target Information

Information on the SPAC target for merger.

Company: Quantum-Si
Presentation: Investor Presentation (SEC) on 2021-02-18
New Ticker: QSI QSIAW
Description: Quantum-Si is "a pioneer in next generation semiconductor chip-based proteomics."